// App-Quantinova.ai

: Modulation of T-Cell Function and Immune Phenotype in the Microenvironment of Emu-TCL1 CLL Bearing Mice By Ibrutinib

Researchers

Presenter

  • Mark-Alexander Schwarzbich

Principal Investigators

  • Arantxa Romero-Toledo

  • John G. Gribben

Medical Centers

  • Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

  • Dept. of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

Locations

  • United Kingdom

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Bruton tyrosine kinase

Drug/Treatment

  • Ibrutinib

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved